Dr. Falchook completed his oncology training at U.T. MD Anderson Cancer Center, where he also served as a faculty member for six years, developing investigator-initiated clinical trials, as well as collaborating with biotech industry partners to bring promising new drugs to cancer patients. Dr. Falchook has been the principal investigator or co-investigator of more than 200 clinical studies, including first-in-human studies and regimens that have received FDA approval. His research has been published extensively, including in the New England Journal of Medicine and The Lancet, with more than 140 publications in peer-reviewed journals, as well as more than 250 abstracts at national and international conferences.